传艺科技(002866.SZ)拟回购注销22.72万股限制性股票及注销34.68万份股票期权
格隆汇1月14日丨传艺科技(002866.SZ)公布,,鉴于公司《激励计划》的首次授予激励对象16人已经离职,同意将上述激励对象已获授但尚未解锁的限制性股票合计22.72万股进行回购注销,占授予限制性股票总量的4.97%;并将其已获授但尚未获准行权的合计34.68万份股票期权进行注销,占授予股票期权总量的5.10%。
根据公司《激励计划》,本次回购注销限制性股票的价格为5.62元/股加上银行同期存款利息之和。公司将使用自有资金进行回购。
本次回购注销完成后,公司总股本将由247,775,390股变更为248,470,790股。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.